Insuline Medical Market Capitalization vs. Book Value Per Share
| INSL Stock | ILS 230.00 20.00 9.52% |
For Insuline Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Insuline Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Insuline Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Insuline Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Insuline Medical over time as well as its relative position and ranking within its peers.
Insuline |
Insuline Medical Book Value Per Share vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Insuline Medical's current stock value. Our valuation model uses many indicators to compare Insuline Medical value to that of its competitors to determine the firm's financial worth. Insuline Medical is rated second overall in market capitalization category among its peers. It also is rated second overall in book value per share category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Insuline Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insuline Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Insuline Market Capitalization vs. Competition
Insuline Medical is rated second overall in market capitalization category among its peers. Market capitalization of Medical Devices industry is currently estimated at about 444.85 Million. Insuline Medical holds roughly 36.33 Million in market capitalization claiming about 8% of all equities under Medical Devices industry.
Insuline Book Value Per Share vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Insuline Medical |
| = | 36.33 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Insuline Medical |
| = | (0.16) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Insuline Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Insuline Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Insuline Medical will eventually generate negative long term returns. The profitability progress is the general direction of Insuline Medical's change in net profit over the period of time. It can combine multiple indicators of Insuline Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel. Insuline Medical is traded on Tel Aviv Stock Exchange in Israel.
Insuline Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Insuline Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Insuline Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Insuline Medical's important profitability drivers and their relationship over time.
Use Insuline Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Insuline Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insuline Medical will appreciate offsetting losses from the drop in the long position's value.Insuline Medical Pair Trading
Insuline Medical Pair Trading Analysis
The ability to find closely correlated positions to Insuline Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Insuline Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Insuline Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Insuline Medical to buy it.
The correlation of Insuline Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Insuline Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Insuline Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Insuline Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Insuline Medical position
In addition to having Insuline Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Latest Losers Thematic Idea Now
Latest Losers
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 243 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Insuline Stock
To fully project Insuline Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Insuline Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Insuline Medical's income statement, its balance sheet, and the statement of cash flows.